Skip to content
Journal ArticlePreprintResearch square·Graded and published ·Last edited

Vitamin B3 Form Gets Parkinson's Mice Moving Despite Nerve Loss

Graded Preliminary — an animal experiment with small groups of mostly eight mice, not yet peer reviewed; whether the results carry over to people is unknown.

Animal study. Findings may not carry over to people, which is why the grade is capped at Preliminary.

Design
Animal study
Participants
8
Duration
—
Funding
US National Institutes of Health (NIA and NIEHS intramural programs, Office of…
Key Insight

In mice with a Parkinson's-like condition, a vitamin B3 form improved movement even though dopamine nerve cells kept dying.


Parkinson's disease destroys the nerve cells that make dopamine, a chemical messenger the brain needs for movement. In mice with a Parkinson's-like condition, nicotinamide riboside got the animals moving more. It is a form of vitamin B3 that cells turn into NAD+, a molecule they need to make energy. The dopamine cells kept dying all the same. What changed was more dopamine release and more energy in the nerve cells.

The mice faced two hits: a faulty protein linked to Parkinson's, plus five weeks of food laced with the fungicide benomyl. Some received the vitamin compound in their drinking water. With eight mice per group, treated sick animals covered longer distances in an open test arena at every check. On a spinning rod they partly held on longer. Injections of the compound raised dopamine release in sick and healthy mice alike. A measure of cell energy rose from day three on.

This is a preprint that experts have not yet reviewed, and the groups were small. The authors say it is still unclear how the compound boosts dopamine release. Whether people with Parkinson's would benefit was not tested.

Disclaimer: Research summaries are provided for informational purposes only and do not constitute medical advice. Always consult a qualified healthcare professional before making changes to your health routine.